Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

233 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Knocking the Wnt out of the sails of leukemia stem cell development.
Deshpande AJ, Buske C. Deshpande AJ, et al. Cell Stem Cell. 2007 Dec 13;1(6):597-8. doi: 10.1016/j.stem.2007.11.006. Cell Stem Cell. 2007. PMID: 18371398 Review.
[Pathogenesis and biology of leukemias].
Feuring-Buske M, Hiddemann W, Buske C. Feuring-Buske M, et al. Internist (Berl). 2002 Oct;43(10):1179-89. doi: 10.1007/s00108-002-0701-y. Internist (Berl). 2002. PMID: 12524900 Review. German. No abstract available.
Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.
Rawat VP, Cusan M, Deshpande A, Hiddemann W, Quintanilla-Martinez L, Humphries RK, Bohlander SK, Feuring-Buske M, Buske C. Rawat VP, et al. Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):817-22. doi: 10.1073/pnas.0305555101. Epub 2004 Jan 12. Proc Natl Acad Sci U S A. 2004. PMID: 14718672 Free PMC article.
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice.
Schessl C, Rawat VP, Cusan M, Deshpande A, Kohl TM, Rosten PM, Spiekermann K, Humphries RK, Schnittger S, Kern W, Hiddemann W, Quintanilla-Martinez L, Bohlander SK, Feuring-Buske M, Buske C. Schessl C, et al. J Clin Invest. 2005 Aug;115(8):2159-68. doi: 10.1172/JCI24225. Epub 2005 Jul 14. J Clin Invest. 2005. PMID: 16025155 Free PMC article.
Towards a pathogenesis-oriented therapy of acute myeloid leukemia.
Hiddemann W, Spiekermann K, Buske C, Feuring-Buske M, Braess J, Haferlach T, Schoch C, Kern W, Schnittger S, Berdel W, Wörmann B, Heinecke A, Sauerland C, Büchner T; German AML Cooperative Group. Hiddemann W, et al. Crit Rev Oncol Hematol. 2005 Nov;56(2):235-45. doi: 10.1016/j.critrevonc.2005.07.004. Epub 2005 Oct 3. Crit Rev Oncol Hematol. 2005. PMID: 16207531 Review.
AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia.
Kuchenbauer F, Feuring-Buske M, Buske C. Kuchenbauer F, et al. Cell Cycle. 2005 Dec;4(12):1716-8. doi: 10.4161/cc.4.12.2256. Epub 2005 Dec 14. Cell Cycle. 2005. PMID: 16294039
These data are supported by observations in AML patients, who recurrently show activating mutations of the receptor tyrosine kinase FLT3 or c-KIT together with the AML1-ETO fusion gene. ...
These data are supported by observations in AML patients, who recurrently show activating mutations of the receptor tyrosine kinase FLT3 or …
[Stem cell therapy. Biology of hematopoietic stem cells].
Buske C, Glimm H, Feuring-Buske M. Buske C, et al. Internist (Berl). 2006 May;47(5):459-60, 462-4. doi: 10.1007/s00108-006-1602-2. Internist (Berl). 2006. PMID: 16575612 German.
[Diagnostics and therapy of acute myeloid leukemia].
Fritsch S, Metzeler K, Hiddemann W, Buske C. Fritsch S, et al. Dtsch Med Wochenschr. 2006 Oct 27;131(43):2401-6. doi: 10.1055/s-2006-955022. Dtsch Med Wochenschr. 2006. PMID: 17054056 Review. German. No abstract available.
233 results
Jump to page
Feedback